Affiliations 

  • 1 Department of Cardiac Surgery, Cardiothoracic Center of Monaco, Monaco; Department of Cardiac Surgery, National Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address: gdreyfus@ccm.mc
  • 2 Department of Cardiology, Piedmont Heart, Atlanta, Georgia
  • 3 Department of Cardiac Surgery, Cardiothoracic Center of Monaco, Monaco; Department of Cardiac Surgery, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Cardiac Surgery, Sarawak General Hospital Heart Center, Kuching, Sarawak, Malaysia
  • 4 Department of Cardiac Surgery, Cardiothoracic Center of Monaco, Monaco
  • 5 Department of Cardiology, Cardiothoracic Center of Monaco, Monaco
J Am Coll Cardiol, 2015 Jun 2;65(21):2331-6.
PMID: 26022823 DOI: 10.1016/j.jacc.2015.04.011

Abstract

The assessment of the etiology and severity of functional tricuspid regurgitation (FTR) has many limitations, especially when tricuspid regurgitation (TR) is more than severe. Instead of relying solely on TR severity, a new approach not only takes into account the severity of TR, but also pays strict attention to tricuspid annular dilation (size), the mode of tricuspid leaflet coaptation, and tricuspid leaflet tethering-factors often influenced by right ventricular enlargement and dysfunction. To simplify things, we propose a new staging system for functional tricuspid valve pathology using 3 parameters that may more accurately reflect the severity of the disease: TR severity, annular dilation, and mode of leaflet coaptation (extent of tethering). We believe that by utilizing these parameters, cardiologists and cardiac surgeons will be offered a better system for appraisal and decision-making in FTR.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.